NCT04806425View on ClinicalTrials.gov

The Cardioprotective Effect of Intralipid in Decreasing the Ischemic Insults During Off-pump Coronary Artery Revascularization

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

February 20, 2021

Study Completion Date

March 1, 2021

Conditions
Anesthesia
Interventions
DRUG

Intralipid

intralipid is given as a preconditioning drug during off bump coronary artery bypass grafting surgery to measure efficacy in decreasing post operative ischemia

DRUG

Placebo

normal saline is given in same volume to normal saline group over the same duration

Trial Locations (1)

11566

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04806425 - The Cardioprotective Effect of Intralipid in Decreasing the Ischemic Insults During Off-pump Coronary Artery Revascularization | Biotech Hunter | Biotech Hunter